Stereotactic radiosurgery in combination with high-dose methotrexate in the treatment of primary central nervous system lymphoma

被引：0
|
作者：
Long, H. [1 ]
机构：
[1] Southern Med Univ, Dept Neurosurg, Nanfang Hosp, Affiliated South Hosp, Guangzhou, Guangdong, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
122P
引用
收藏
页码：36 / 36
页数：1
相关论文
共 50 条
  • [41] THERAPEUTIC EFFECT OF INDUCTION OF POLYGLUTAMYLATION IN HIGH-DOSE METHOTREXATE THERAPY TO PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
    Fujimoto, Kenji
    Shinojima, Naoki
    Makino, Keishi
    Ichimura, Koichi
    Mukasa, Akitake
    [J]. NEURO-ONCOLOGY, 2019, 21 : 34 - 34
  • [42] Primary central nervous system lymphoma treated with high-dose methotrexate and rituximab: Preliminary results in Vietnam
    Hoang, G. H. Nguyen
    Nguyen, P. T. B.
    Nguyen, H. T. N.
    Do, K. H.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [43] High-dose methotrexate following intravitreal methotrexate administration in preventing central nervous system involvement of primary intraocular lymphoma
    Akiyama, Hiroki
    Takase, Hiroshi
    Kubo, Fumito
    Miki, Tohru
    Yamamoto, Masahide
    Tomita, Makoto
    Mochizuki, Manabu
    Miura, Osamu
    Arai, Ayako
    [J]. CANCER SCIENCE, 2016, 107 (10) : 1458 - 1464
  • [44] Primary central nervous system lymphomas: Salvage treatment after failure to high-dose methotrexate
    Reni, Michele
    Mazza, Elena
    Foppoli, Marco
    Ferreri, Andres J. M.
    [J]. CANCER LETTERS, 2007, 258 (02) : 165 - 170
  • [45] Analysis of high-dose methotrexate with rituximab versus other treatment regimens for primary central nervous system (CNS) lymphoma.
    Lindhorst, Scott Michael
    McSherry, Frances
    Desjardins, Annick
    Friedman, Henry S.
    Peters, Katherine B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [46] Combined treatment with high-dose methotrexate and whole brain radiation improves survival in primary central nervous system lymphoma (PCNSL)
    Abdelsalam, M. A.
    Hussainy, G.
    Akhtar, S.
    Maghfoor, I.
    Elweshi, A.
    Khafaga, Y.
    Alhuseini, H.
    Rahal, M.
    Alshabana, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [47] Comparable outcomes of radiation therapy without high-dose methotrexate for patients with primary central nervous system lymphoma
    Ishikawa, H
    Hasegawa, M
    Tamaki, Y
    Hayakawa, K
    Akimoto, T
    Sakurai, H
    Mitsuhashi, N
    Niibe, H
    Tamura, M
    Nakano, T
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2003, 33 (09) : 443 - 449
  • [48] Tirabrutinib maintenance therapy for a patient with high-dose methotrexate-ineligible primary central nervous system lymphoma
    Okamura, Tadashi
    Hosoi, Hiroki
    Matsufusa, Takeshi
    Akagi, Yuina
    Iwamoto, Ryuta
    Kosako, Hideki
    Murata, Shogo
    Mushino, Toshiki
    Murata, Shin-Ichi
    Sonoki, Takashi
    [J]. ANNALS OF HEMATOLOGY, 2022, 101 (06) : 1379 - 1381
  • [49] NOA-03 trial of high-dose methotrexate in primary central nervous system lymphoma:: Final report
    Herrlinger, U
    Küker, W
    Uhl, M
    Blaicher, HP
    Karnath, HO
    Kanz, L
    Bamberg, M
    Weller, M
    [J]. ANNALS OF NEUROLOGY, 2005, 57 (06) : 843 - 847
  • [50] High-dose methotrexate combined with rituximab improves the survival rate of patients with primary central nervous system lymphoma
    Ma, Jing
    Ma, Xianjun
    [J]. JOURNAL OF BUON, 2021, 26 (02): : 366 - 372
12345